Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma

Hamid, Omid; Puzanov, Igor; Dummer, Reinhard; Schachter, Jacob; Daud, Adil; Schadendorf, Dirk; Blank, Christian; Cranmer, Lee D; Robert, Caroline; Pavlick, Anna C; Gonzalez, Rene; Hodi, F Stephen; Ascierto, Paolo A; Salama, April K S; Margolin, Kim A; Gangadhar, Tara C; Wei, Ziwen; Ebbinghaus, Scot; Ibrahim, Nageatte; Ribas, Antoni

research article review journal article

oai:www.zora.uzh.ch:141945

Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma

Authors: Omid Hamid
Igor Puzanov
Reinhard Dummer
Jacob Schachter
Adil Daud
Dirk Schadendorf
Christian Blank
Lee D Cranmer
Caroline Robert
Anna C Pavlick
Rene Gonzalez
F Stephen Hodi
Paolo A Ascierto
April K S Salama
Kim A Margolin
Tara C Gangadhar
Ziwen Wei
Scot Ebbinghaus
Nageatte Ibrahim
Antoni Ribas
Publication date: 1 November 2017
Publisher: Elsevier
Doi

Abstract

Abstract is not available.

Similar works

Full text

ZORA

oai:www.zora.uzh.ch:141945

Last time updated on 02/12/2017

This paper was published in ZORA.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.